These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19879921)

  • 1. The amyloid-beta25-35 injection into the CA1 region of the neonatal rat hippocampus impairs the long-term memory because of an increase of nitric oxide.
    Díaz A; De Jesús L; Mendieta L; Calvillo M; Espinosa B; Zenteno E; Guevara J; Limón ID
    Neurosci Lett; 2010 Jan; 468(2):151-5. PubMed ID: 19879921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-beta(25-35) impairs memory and increases NO in the temporal cortex of rats.
    Limón ID; Díaz A; Mendieta L; Chamorro G; Espinosa B; Zenteno E; Guevara J
    Neurosci Res; 2009 Feb; 63(2):129-37. PubMed ID: 19084561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of long-term administration of ferulic acid on astrocyte activation induced by intracerebroventricular injection of beta-amyloid peptide (1-42) in mice.
    Cho JY; Kim HS; Kim DH; Yan JJ; Suh HW; Song DK
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):901-7. PubMed ID: 15970368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant effects of epicatechin on the hippocampal toxicity caused by amyloid-beta 25-35 in rats.
    Cuevas E; Limón D; Pérez-Severiano F; Díaz A; Ortega L; Zenteno E; Guevara J
    Eur J Pharmacol; 2009 Aug; 616(1-3):122-7. PubMed ID: 19540227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes.
    de la Torre JC; Aliev G
    J Cereb Blood Flow Metab; 2005 Jun; 25(6):663-72. PubMed ID: 15703700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silibinin attenuates amyloid beta(25-35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice.
    Lu P; Mamiya T; Lu LL; Mouri A; Niwa M; Hiramatsu M; Zou LB; Nagai T; Ikejima T; Nabeshima T
    J Pharmacol Exp Ther; 2009 Oct; 331(1):319-26. PubMed ID: 19638571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intrahippocampal beta amyloid (1-42) peptide injection on oxidant and antioxidant status in rat brain.
    Cetin F; Dincer S
    Ann N Y Acad Sci; 2007 Apr; 1100():510-7. PubMed ID: 17460216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25-35).
    Stepanichev MY; Zdobnova IM; Yakovlev AA; Onufriev MV; Lazareva NA; Zarubenko II; Gulyaeva NV
    J Neurosci Res; 2003 Jan; 71(1):110-20. PubMed ID: 12478619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble beta-amyloid[25-35] reversibly impairs hippocampal synaptic plasticity and spatial learning.
    Holscher C; Gengler S; Gault VA; Harriott P; Mallot HA
    Eur J Pharmacol; 2007 Apr; 561(1-3):85-90. PubMed ID: 17320856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of NOS in the impairment of spatial memory and damaged neurons in rats injected with amyloid beta 25-35 into the temporal cortex.
    Diaz A; Mendieta L; Zenteno E; Guevara J; Limon ID
    Pharmacol Biochem Behav; 2011 Mar; 98(1):67-75. PubMed ID: 21163295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-beta(25-35)-induced memory impairments correlate with cell loss in rat hippocampus.
    Stepanichev MY; Zdobnova IM; Zarubenko II; Moiseeva YV; Lazareva NA; Onufriev MV; Gulyaeva NV
    Physiol Behav; 2004 Feb; 80(5):647-55. PubMed ID: 14984798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of the sialylation pattern and memory deficits by injection of Aβ(25-35) into the hippocampus of rats.
    Limón ID; Ramírez E; Díaz A; Mendieta L; Mayoral MÁ; Espinosa B; Guevara J; Zenteno E
    Neurosci Lett; 2011 May; 495(1):11-6. PubMed ID: 21419829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine vasopressin prevents against Abeta(25-35)-induced impairment of spatial learning and memory in rats.
    Pan YF; Chen XR; Wu MN; Ma CG; Qi JS
    Horm Behav; 2010 Apr; 57(4-5):448-54. PubMed ID: 20138885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of systemic L-kynurenine and probenecid administration on behavioural and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus.
    Carrillo-Mora P; Méndez-Cuesta LA; Pérez-De La Cruz V; Fortoul-van Der Goes TI; Santamaría A
    Behav Brain Res; 2010 Jul; 210(2):240-50. PubMed ID: 20219555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-sheet breaker peptide prevents Abeta-induced spatial memory impairments with partial reduction of amyloid deposits.
    Chacón MA; Barría MI; Soto C; Inestrosa NC
    Mol Psychiatry; 2004 Oct; 9(10):953-61. PubMed ID: 15098004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of memantine on soluble Alphabeta(25-35)-induced changes in peptidergic and glial cells in Alzheimer's disease model rat brain regions.
    Arif M; Chikuma T; Ahmed MM; Nakazato M; Smith MA; Kato T
    Neuroscience; 2009 Dec; 164(3):1199-209. PubMed ID: 19733635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
    Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of central administration of beta-amyloid peptide (25-35): pathomorphological changes in the hippocampus and impairments of spatial memory].
    Stepanichev MIu; Zdobnova IM; Zarubenko II; Lazareva NA; Guliaeva NV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2004; 54(5):705-11. PubMed ID: 15573708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential susceptibility following beta-amyloid peptide-(1-40) administration in C57BL/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response.
    Prediger RD; Franco JL; Pandolfo P; Medeiros R; Duarte FS; Di Giunta G; Figueiredo CP; Farina M; Calixto JB; Takahashi RN; Dafre AL
    Behav Brain Res; 2007 Feb; 177(2):205-13. PubMed ID: 17194489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of tumor necrosis factor-alpha co-administered with amyloid beta-peptide (25-35) on memory function and hippocampal damage in rat.
    Stepanichev M; Zdobnova I; Zarubenko I; Lazareva N; Gulyaeva NV
    Behav Brain Res; 2006 Dec; 175(2):352-61. PubMed ID: 17070605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.